Pediatric Retinal Diseases and Systemic Cancer and the Eye

Dr William Deegan recently spoke to the National Capital Region Federal Optometric Society (NCRFOS) on Friday April 8 at the Navy Yards.  The NCRFOS represents active duty optometrists in the National Capital Region. He spoke on  Pediatric Retinal Diseases and Systemic Cancer and the Eye.

To learn more about Pediatric Retinal Diseases and Systemic Cancer and the Eye click here.

 

SPECTRI Trial in Chevy Chase

“ Dr. Richard Garfinkle presented the protocol of the ongoing SPECTRI trial to eye specialists in Northern Virginia.  SPECTRI is an ongoing clinical trial examining the role of lampalizumab for the treatment of geographic atrophy in macular degeneration.  This represents the first major, interventional trial in dry macular degeneration.  The Retina Group of Washington is the only practice in the DC metropolitan area participating in this pivotal, cutting-edge trial. “

 

 

For more about SPECTRI trial click here.

New York Times – Ask Well: Floaters in the Eye

What causes floaters in the eye?

Floaters, those small dots or cobweb-shaped patches that move or “float” through the field of vision, can be alarming. Though many are harmless, if you develop a new floater, “you need to be seen pretty quickly” by an eye doctor in order to rule out a retinal tear or detachment, said Dr. Rebecca Taylor, a spokeswoman for the American Academy of Ophthalmology.

Floaters are caused by clumping of the vitreous humor, the gel-like fluid that fills the inside of the eye. Normally, the vitreous gel is anchored to the back of the eye. But as you age, it tends to thin out and may shrink and pull away from the inside surface of the eye, causing clumps or strands of connective tissue to become lodged in the jelly, much as “strands of thread fray when a button comes off on your coat,” Dr. Taylor said. The strands or clumps cast shadows on the retina, appearing as specks, dots, clouds or spider webs in your field of vision.

Such changes may occur at younger ages, too, particularly if you are nearsighted or have had a head injury or eye surgery. There is no treatment for floaters, though they usually fade with time.

But it’s still important to see a doctor if new floaters arise because the detaching vitreous gel can pull on the retina, causing it to tear, which can lead to retinal detachment, a serious condition. The pulling or tugging on the retina may be perceived as lightning-like flashes, “like a strobe light off to the side of your vision,” Dr. Taylor said.

See an eye doctor within 24 to 48 hours if you have a new floater, experience a sudden “storm” of floaters, see a gray curtain or shadow move across your field of vision, or have a sudden decrease in vision.

To learn more please call one of our ophthalmologists in Chevy Chase at (301) 656-8100.

Rabin, Roni Caryn. “Ask Well: Floaters in the Eye.” Well Ask Well Floaters in the Eye Comments. New York TImes, 5 Feb. 2016. Web. 11 Feb. 2016.

 

RGW Selects Modernizing Medicine, Inc., for EMA

Modernizing Medicine, Inc., the creator of the Electronic Medical Assistant® (EMA™), a cloud-based, iPad native, specialty-specific electronic medical record (EMR) system, announced today that The Retina Group of Washington has selected EMA Ophthalmology to replace its legacy EMR solution. Use of the highly specialized EMR system will help streamline physician workflows and improve patient care across the entire practice.
With 26 physicians working across 14 offices, The Retina Group of Washington is one of the largest and most highly respected retinal and macular practices in the country. The Retina Group of Washington is well known for its extensive experience and sub-specialty expertise of its leading physicians and surgeons. Deeply committed to the advancement of care, the group is constantly conducting cutting-edge research and administers a Fellowship program to train future ophthalmologists.
“As one of the leading retinal practices in the country, we constantly look for ways to make our physicians’ lives easier and improve care,” said Dr. Michael Rivers, current Board member at The Retina Group of Washington and head of their EMR system selection committee.
For more information click here.

Macular Degeneration in Chevy Chase

Dr. Richard Garfinkle presented a talk titled “Age-Related Macular Degeneration:  New strategies for minimizing and managing vision loss.”  at the Chevy Chase Village Center as part of the “Chevy Chase at Home” community group.

For more information on macular degeneration click here.

Rare Presentation of Endophthalmitis

Dr. Reilly and Dr. Garfinkle published a paper in the journal Ophthalmic Surgery and Lasers reporting an atypical presentation of endophthalmitis in a patient having undergone previous vitrectomy surgery.  Endophthalmitis is a rare but potentially devastating infection that can occur after ocular surgery.  Reporting findings in an atypical case helps other practitioners recognize this condition at an earlier stage allowing for earlier diagnosis and treatment.

 

Read the Article Here

Top Retinal Ophthalmologist In Chevy Chase

Drs.  Reginald J. Sanders and William F. Deegan were selected by their colleagues in the medical field as “Top Doctors” in Ophthalmology as part of the 2015 “Top Doctors” published in the September issue of Washingtonian.  The bi-annual survey,  conducted for the first time online, solicited nominations from more than 12,000 physicians throughout D.C., Maryland and Virginia.  The list is designed to help readers find the best medical care in their communities, including primary care doctors and those specialists whom patients choose for themselves.

Retinal Vein Occlusion in Young Patients

The management of retinal vein occlusion (RVO) has changed dramatically over the last 3 decades since the results of the Branch Vein Occlusion Study (BVOS) and Central Vein Occlusion Study (CVOS) were published in the 1980s and 1990s.

While most patients who present with RVO are 60 years of age or older, young patients can pose particular diagnostic and treatment challenges.

In this installment of Practical Retina, current RGW retina fellow Dr. Luke Lindsell and Dr. Michael Lai from Washington, D.C., address what should be included in an appropriate diagnostic work-up for younger patients who present with RVO, provide pearls for detecting uncommon underlying systemic etiologies, and review their treatment paradigm.

You can read about it in their article entitled “Current concepts in managing retinal vein occlusion in young patients” for the July/August 2015 issue of the journal Ophthalmic Surgery Lasers & Imaging Retina.

Click here to read more.

Source: Ophthalmic Surgery, Lasers and Imaging Retina July 2015 – Volume 46 · Issue 7: 695-701